NPRA

Directory | Consumers

Increase size

Reset to Default

Decrease size

NPRA Banner

New Publication: Reaksi Drug Safety News - Issue 4/2017

: Posted By Jauze; 20 Julai 2017; Jumlah paparan: 18274

Kadar pengguna: 1 / 5

bintang aktif

Bintang tidak aktif

Bintang tidak aktif

Bintang tidak aktif

Bintang tidak aktif

REAKSI Drug Safety News,

Issue 4/2017, Vol. 36

Hyoscine Butylbromide Injection: Risk of Serious Adverse Effects in Patients with Underlying Cardiac Disease
Keytruda® (pembrolizumab): Risk of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)

Rating:

( 1 Rating )

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

Phone: +603-7883 5400

More Links

Privacy & Policy

More Links

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product Status

NPRA Product Status

Site Last Modified

Last Modified: Khamis 19 September 2024, 16:35:40.

Online Services

NPRA Support System

Online Public Engagement

Online Procurement Announcement